From Local anaesthesia for Dental professionals
 Modifications to Local Anesthesia for Common Medical Conditions
Condition 
 | 
Local Anesthetic Considerations 
 | 
Vasoconstrictor Considerations 
 | 
Modifications 
 | 
Diabetes 
 | 
None of Significance 
 | 
Epinephrine opposes the action of insulin 
Minute amounts used in dentistry do not raise blood levels significantly  | 
Use epinephrine withcaution when there is significant cardiovascular disease and/or uncontrolled diabetes. 
 | 
Glaucoma 
 | 
None of Significance 
 | 
Vasoconstrictors cause increased ocular pressure 
 | 
Avoid vasoconstrictors 
 | 
Hypertension 
 | 
None of Significance 
 | 
Vasoconstrictors can increase the risk of hypertensive episodes however the lack of profound anesthesia can increase levels ofendogenous epinephrineControversial topic 
 | 
Clinical judgment and medical consult advised 
Note: Uncontrolled hypertensives eithershould not be treatedor treated with caution, depending upon severity See Table 10-1 ASA Physical Status Classification Blood Pressure Guidelines for Adults  | 
Hyperthyroidism 
A—Controlled  | 
None of Significance 
 | 
Hyperthyroidism appears to increase tissue sensitivity to epinephrine 
 | 
When there is obvious evidence of hyperthyroidism avoidepinephrine 
 | 
Hyperthyroidism 
B—Uncontrolled  | 
None of Significance 
 | 
Risk of seriously increased tissue sensitivity to epinephrine 
 | 
Avoid all treatment until condition is under control 
 | 
Hypothyroidism 
A—Controlled  | 
Generally Safe 
 | 
Generally Safe 
 | 
Hypothyroid patients tend to be sensitive to CNS depressants 
Local anesthetic doses should be kept to aminimum  | 
Hypothyroidism 
B—Poorly Controlled with mild symptoms  | 
Generally Safe 
 | 
Generally Safe 
 | 
Hypothyroid patients tend to be sensitive to CNS depressants 
Caution with LA drug dosing. Hypothermia, bradycardia, severe hypotension and seizures are possible.  | 
Hypothyroidism 
C—Severe or Untreated  | 
Avoid all treatment until condition is under control 
 | ||
Myasthenia Gravis 
 | 
Esters and articaine compete for diminished supplies of acetyl choline 
 | 
None of Significance 
 | 
Avoid esters and articaine 
 | 
Medical Predispositions That May Require Modifications
Condition 
 | 
Local Anesthetic Considerations 
 | 
Vasoconstrictor Considerations 
 | 
Modifications 
 | 
Significant Hepatic Disease 
 | 
Amides are primarily metabolized in the liver 
 | 
Cholinesterase is primarily manufactured in the liver although there are extra-hepatic sources 
 | 
Caution with use of amides Articaine is the preferred amide but appointments should beshorter with reduced dosagesadministered 
If other amides are used, limit even further  | 
Atypical Cholinesterase 
 | 
Amides are not affected 
 | 
None of Significance 
 | 
Avoid esters & articaine 
 | 
Significant Renal Dysfunction 
 | 
All drugs cleared more slowly, with increased risk of overdose 
 | 
All drugs cleared more slowly, with increased risk of overdose 
 | 
Medical consult advised Limitdoses of all drugs depending upon severity 
 | 
Methemoglobinemia 
 | 
Increased risk with prilocaine and benzocaine 
 | 
None of Significance 
 | 
Substitute other amides for prilocaine and other topicals for benzocaine Avoid prilocaine or benzocaine when excessive doses of acetaminophen are used 
 | 
Malignant Hyperthermia 
 | 
local anesthetic agents safe for MH patients: articaine bupivacaine lidocaine mepivacaine prilocaine 
 | 
None of Significance 
 | 
Medical consult is recommended 
When treating these patients follow the MHAUS* guidelines  | 
Modifications to Local Anesthesia for Common Concomitant Drug Therapy
Medications Examples: Proprietary (generic) 
 | 
Local Anesthetic Considerations 
 | 
Vasoconstrictor Considerations 
 | 
Modifications 
 | 
Anticonvulsants 
Klonopin (clonazepam) Dilantin (phenytoin) Depakote (valproic acid) Topamax (topiramate)  | 
Anxiety reduction requires effective local anesthesia. 
Sensitive to CNS depressants  | 
None of Significance 
 | 
Avoid higher doses of local anesthetic drugs 
 | 
Antipsychotics 
Zyprexa (olanzapine) Seroquel (quetiapine) Risperdal (risperidone)  | 
Increased sensitivity to CNS depressants 
 | 
None of Significance 
 | 
Avoid higher doses of local anesthetic drugs 
 | 
Antidepressants Tricyclic 
Elavil (amitriptyline) Tofranil (imipramine)  | 
None of Significance 
 | 
Increases risk of hypertensive episode by opposing the reuptake of norepinephrine 
 | 
Limit doses ofepinephrine(observe cardiac dose limits) 
Avoid levonordefrin  | 
Antidepressants 
Serotonin/Norepinephrine Reuptake Inhibitor Effexor (venlafaxine) Savella (milnacipran)  | 
None of Significance 
 | 
Oppose the reuptake of norepinephrine 
 | 
Suggest caution 
 | 
Antidepressants 
Central Alpha-2 Antagonist Remeron (mirtazapine)  | 
None of Significance 
 | 
Increases release of norepinephrine 
 | 
Suggest caution 
 | 
Antidepressants 
Dopamine Reuptake Inhibitor Wellbutrin (Bupropion) Zyban (Bupropion)  | 
None of Significance 
 | 
Oppose the reuptake of norepinephrine 
 | 
Suggest caution 
 | 
Antidepressants 
Other Cymbalta (duloxetine)  | 
None of Significance 
 | 
Oppose the reuptake of norepinephrine 
 | 
Suggest caution 
 | 
Anxiolytics 
Valium (diazepam)  | 
CNS depressant effect of local anesthetics may be additive 
 | 
None of Significance 
 | 
Limit dosages 
 | 
Glucocorticoids 
Nasonex (mometasone) Entocort (budesonide) Advair (fluticasone) Aristocort (triamcinolone)  | 
Stress associated with local anesthesia is considered to be low 
 | 
Stress associated with local anesthesia is considered to be low 
 | 
Considersupplemental stress reduction such as nitrous oxide or IV sedation 
 | 
With propranolol, minimal doses of lidocaine are recommended 
 | 
Increased risk of hypertensive episode and reflexive bradycardia and in a few individuals, strokes 
 | 
Unless vasoconstriction is necessary, limit or avoidvasoconstrictors 
 | |
Histamine H2 Receptor Blockers 
Tagamet (cimetidine) Zantac (ranitidine)  | 
Tagamet competes with lidocaine for liver isoenzymes 
Slows lidocaine metabolism increasing the risk of overdose Zantac and others do not have this effect  | 
None of Significance 
 | 
Use caution with large doses of lidocaine particularly in the presence of significant congestive heart failure 
 | 
Monoamine Oxidase Inhibitors 
Nardil (phenelzine) Parnate (tranylcypromine) Marplan (isocarboxazid)  | 
None of Significance 
 | 
None of Significance 
 | 
None 
 | 
Phenothiazinesantipsychotic/antiemetic/neuroleptics 
Thorazine (chlorpromazine) Mellaril (thioridazine)  | 
None of Significance 
 | 
Hypotension, possibly severe, is the primary effect of epinephrine with these drugs 
 | 
Observe cardiaclimit of vasoconstrictors (0.04 mg). 
Do not use 1:50,000epinephrine  | 
Limited examples are provided in each category; numerous drugs may be included in these categories. Current drug indexes should be consulted for the most up-to-date information. 
 | |||
Illegal ("Recreational") Drug Use*
Drug 
 | 
Local Anesthetic Considerations 
 | 
Vasoconstrictor Considerations 
 | 
Modifications 
 | 
Methamphetamine 
 | 
None of Significance 
 | 
Administration of vasoconstrictors may result in hypertensive crisis, stroke, or myocardial infarction 
 | 
Do not administer local anesthetics with vasoconstrictors for a minimum of 24 hours after methamphetamine use 
 | 
Cocaine 
 | 
Cocaine is a strong CNS depressant; local anesthetics compound CNS depression and administration should beavoided 
 | 
Administration of vasoconstrictors significantly increases the risk of hypertensive crisis, stroke, or myocardial infarction 
 | 
Do not administer local anesthetics with vasoconstrictors for a minimum of 24 hours after cocaine use 
 | 
Alcohol 
 | 
May decrease the effectiveness of local anesthetics 
 | 
None of Significance 
 | 
Use caution to avoid overdose 
 | 
Comments
Post a Comment
Please leave a comment and let me know what you think or if there are any topics you would like covered in the future